Brener, Sorin Jakob

Publications

Sort by

Co-Author Network

selected publications

Descending Aortic Distensibility and Cardiovascular Outcomes: A Cardiac Magnetic Resonance Imaging Study. Vascular health and risk management. 2022 Academic Article GET IT
In-Hospital Mortality of Index Percutaneous Coronary Intervention in Patients With and Without Prior Percutaneous Revascularization: A Single-Institution Analysis. Cardiovascular revascularization medicine : including molecular interventions. 2022 Academic Article GET IT
Times cited: 1
Analysis of clinical risk models vs. clinician's assessment for prediction of coronary artery disease among predominantly female population. Coronary artery disease. 2022 Academic Article GET IT
Times cited: 1
What Happened to the Cycle of Knowledge?. Circulation. Cardiovascular interventions. 2021 Editorial Article GET IT
Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk Analysis. Journal of the American College of Cardiology. 2021 Editorial Article GET IT
Times cited: 1
A Novel Risk Score to Predict One-Year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI). The Journal of invasive cardiology. 2021 Academic Article GET IT
Times cited: 7
Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2020 Academic Article GET IT
Times cited: 2
At the Intersection of Logic and Statistics: Is Proximal Left Anterior Descending Artery Revascularization Still a Notable Event?. JACC. Cardiovascular interventions. 2020 Editorial Article GET IT
Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Coronary artery disease. 2020 Academic Article GET IT
Times cited: 3
An Updated Healthcare System-Wide Clinical Pathway for Managing Patients With Chest Pain and Acute Coronary Syndromes. Critical pathways in cardiology. 2019 Academic Article GET IT
Times cited: 5
High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction. American heart journal. 2019 Academic Article GET IT
Times cited: 6
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. International journal of cardiology. 2019 Review GET IT
Times cited: 31
Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2019 Academic Article GET IT
Times cited: 3
Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry. The Journal of invasive cardiology. 2019 Academic Article GET IT
Times cited: 2
The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: A systematic review and meta-analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2019 Review GET IT
Times cited: 22
Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2019 Academic Article GET IT
Times cited: 4
Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting. Journal of the American College of Cardiology. 2018 Letter GET IT
Times cited: 18
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circulation. Cardiovascular interventions. 2018 Academic Article GET IT
Times cited: 14
Transcatheter versus surgical aortic valve replacement in low- and intermediate-risk patients: an updated systematic review and meta-analysis. Cardiovascular intervention and therapeutics. 2018 Review GET IT
Times cited: 33
Cardiovascular and Noncardiovascular Death After Percutaneous Coronary Intervention: Insights From 32 882 Patients Enrolled in 21 Randomized Trials. Circulation. Cardiovascular interventions. 2018 Academic Article GET IT
Times cited: 20
Impact of On-Site Surgical Backup on Periprocedural Outcomes of Primary Percutaneous Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction (From the ORPKI Polish National Registry). The American journal of cardiology. 2018 Academic Article GET IT
Times cited: 5
Whose Urgency Is it, Anyway?. JACC. Cardiovascular interventions. 2018 Editorial Article GET IT
The SYNTAX II Score Predicts Mortality at 4 Years in Patients Undergoing Percutaneous Coronary Intervention. The Journal of invasive cardiology. 2018 Academic Article GET IT
Times cited: 6
I so wish it were true… "If it seems too good to be true, it probably is". Postepy w kardiologii interwencyjnej = Advances in interventional cardiology. 2018 Editorial Article GET IT
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. International journal of cardiology. 2017 Academic Article GET IT
Times cited: 14
Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. Journal of the American College of Cardiology. 2017 Academic Article GET IT
Times cited: 49
Efficacy and safety of potent platelet P2Y12 receptor inhibitors in elderly versus nonelderly patients with acute coronary syndrome: A systematic review and meta-analysis. American heart journal. 2017 Review GET IT
Times cited: 23
Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. European heart journal. Acute cardiovascular care. 2017 Academic Article GET IT
Times cited: 13
Accurate prediction of coronary and cerebrovascular events: Adding small pieces to an emerging puzzle. Atherosclerosis. 2017 Editorial Article GET IT
Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction. PloS one. 2017 Academic Article GET IT
Times cited: 11
Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study). The American journal of cardiology. 2017 Academic Article GET IT
Times cited: 24
Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). The American journal of cardiology. 2017 Academic Article GET IT
Times cited: 30
More Bad News for Patients With Diabetes and a Thin Silver Lining. JACC. Cardiovascular interventions. 2017 Editorial Article GET IT
Times cited: 1
Meta-Analysis of the Optimal Percutaneous Revascularization Strategy in Patients With Acute Myocardial Infarction, Cardiogenic Shock, and Multivessel Coronary Artery Disease. The American journal of cardiology. 2017 Review GET IT
Times cited: 6
Reply: Treatment Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Is Staged PCI Truly the Best Option?. JACC. Cardiovascular interventions. 2017 Letter GET IT
Beware of calcium, but respect the narrowing. Atherosclerosis. 2017 Editorial Article GET IT
Should We Measure Biomarkers for Myonecrosis Before and After PCI?. Journal of the American College of Cardiology. 2016 Editorial Article GET IT
Times cited: 2
Fixed lesions or coronary spasm? The choice is clear…. Atherosclerosis. 2016 Editorial Article GET IT
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis. JACC. Cardiovascular interventions. 2016 Review GET IT
Times cited: 50
Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). The American journal of cardiology. 2016 Academic Article GET IT
Times cited: 16
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study. JACC. Cardiovascular interventions. 2016 Academic Article GET IT
Times cited: 31
Numbers, Numbers, Numbers…So Many Details Hide in Plain Sight! Insights From HEAT-PPCI and HEAT-SEALED. The Journal of invasive cardiology. 2016 Editorial Article GET IT
Corin Levels in Patients With Acute MI: Do We Need More Tools for Risk Stratification?. Journal of the American College of Cardiology. 2016 Editorial Article GET IT
Times cited: 1
Biomarker ratios and acute myocardial infarction: when one goes up and the other goes down. Coronary artery disease. 2016 Editorial Article GET IT
Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials. The American journal of cardiology. 2016 Academic Article GET IT
Times cited: 7
Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2016 Academic Article GET IT
Times cited: 1
Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2016 Academic Article GET IT
Times cited: 15
Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials. JACC. Cardiovascular interventions. 2016 Academic Article GET IT
Times cited: 13
Cardiac Amyloidosis Presenting With Cardiogenic Shock. 2016 GET IT
Times cited: 2
Efficacy and Safety of Prasugrel Compared With Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. American journal of therapeutics. 2016 Academic Article GET IT
Times cited: 2
Fogarty Maneuver to Restore Coronary Flow in ST-Segment Elevation Myocardial Infarction: Desperate Times Call for Desperate Measures. 2016 GET IT
Times cited: 1
Pretreatment with aspirin in acute coronary syndromes: Lessons from the ACUITY and HORIZONS-AMI trials. European heart journal. Acute cardiovascular care. 2015 Academic Article GET IT
Times cited: 8
Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction). JACC. Cardiovascular interventions. 2015 Academic Article GET IT
Times cited: 45
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study. Circulation. Cardiovascular interventions. 2015 Academic Article GET IT
Times cited: 13
Do pulmonary function tests improve risk stratification before cardiothoracic surgery?. The Journal of thoracic and cardiovascular surgery. 2015 Academic Article GET IT
Times cited: 18
Usefulness of the Left Anterior Descending Coronary Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). The American journal of cardiology. 2015 Academic Article GET IT
Times cited: 11
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials. Circulation. Cardiovascular interventions. 2015 Academic Article GET IT
Times cited: 126
Reduced Right Ventricular Function Predicts Long-Term Cardiac Re-Hospitalization after Cardiac Surgery. PloS one. 2015 Academic Article GET IT
Times cited: 25
Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study. The Journal of invasive cardiology. 2015 Academic Article GET IT
Times cited: 3
Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2015 Academic Article GET IT
Times cited: 26
Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. The Journal of invasive cardiology. 2015 Academic Article GET IT
Times cited: 7
Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention. The Canadian journal of cardiology. 2015 Academic Article GET IT
Times cited: 39
Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents? All patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy. Circulation. 2015 Review GET IT
Times cited: 2
Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial. Circulation. Cardiovascular interventions. 2015 Academic Article GET IT
Times cited: 5
Cost implications of intraprocedural thrombotic events during PCI. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2015 Academic Article GET IT
Times cited: 4
Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy). The American journal of cardiology. 2015 Academic Article GET IT
Times cited: 13
Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial. Circulation. Cardiovascular interventions. 2015 Academic Article GET IT
Times cited: 16
The Evolution of Coronary Revascularization Appropriateness Use Criteria: From Mandatory to Forgotten. Reviews in cardiovascular medicine. 2015 Academic Article GET IT
Times cited: 1
Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 51
Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI. American heart journal. 2014 Academic Article GET IT
Times cited: 11
Correlation between markers of reperfusion and mortality in ST-elevation myocardial infarction: a systematic review. The Journal of invasive cardiology. 2014 Review GET IT
Times cited: 9
Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acute myocardial infarction (from the MGuard for acute ST elevation reperfusion trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 22
Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2014 Academic Article GET IT
Times cited: 15
Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial. Cardiovascular revascularization medicine : including molecular interventions. 2014 Academic Article GET IT
Times cited: 7
Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 6
Impact of pre-procedural cardiopulmonary instability in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 2
Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI). American heart journal. 2014 Academic Article GET IT
Times cited: 14
Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction). JACC. Cardiovascular interventions. 2014 Academic Article GET IT
Times cited: 43
Pharmacologic therapy for reducing myocardial infarct size in clinical trials: failed and promising approaches. Journal of cardiovascular pharmacology and therapeutics. 2014 Review GET IT
Times cited: 8
Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial. Circulation. Cardiovascular interventions. 2014 Academic Article GET IT
Times cited: 61
SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2014 Academic Article GET IT
Times cited: 25
Utilization of trained volunteers decreases 30-day readmissions for heart failure. Journal of cardiac failure. 2014 Academic Article GET IT
Times cited: 6
Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 32
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. European heart journal. 2014 Academic Article GET IT
Times cited: 175
Impact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 12
Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. Journal of the American College of Cardiology. 2014 Academic Article GET IT
Times cited: 310
Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 33
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014 Academic Article GET IT
Times cited: 15
Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). The American journal of cardiology. 2014 Academic Article GET IT
Times cited: 14
Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 22
Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials. American heart journal. 2013 Review GET IT
Times cited: 23
Reply: relationship between myocardial reperfusion, infarct size, and mortality. JACC. Cardiovascular interventions. 2013 Letter GET IT
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2013 Academic Article GET IT
Times cited: 14
Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial. American heart journal. 2013 Academic Article GET IT
Times cited: 47
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention). Journal of the American College of Cardiology. 2013 Academic Article GET IT
Times cited: 85
Utilization of trained volunteers decreases 30-day readmissions for heart failure. Journal of cardiac failure. 2013 Academic Article GET IT
Times cited: 25
Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2013 Academic Article GET IT
Times cited: 18
Radial versus femoral access. Journal of the American College of Cardiology. 2013 Review GET IT
Times cited: 23
Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 68
Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial. European heart journal. Acute cardiovascular care. 2013 Academic Article GET IT
Times cited: 19
Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 28
Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 36
Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial. Circulation. Cardiovascular interventions. 2013 Academic Article GET IT
Times cited: 51
Leukocyte count is a modulating factor for the mortality benefit of bivalirudin in ST-segment-elevation acute myocardial infarction: the HORIZONS-AMI trial. Circulation. Cardiovascular interventions. 2013 Academic Article GET IT
Times cited: 16
Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 20
Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial. American heart journal. 2013 Academic Article GET IT
Times cited: 20
Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 38
Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. JACC. Cardiovascular interventions. 2013 Academic Article GET IT
Times cited: 40
Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Journal of interventional cardiology. 2013 Academic Article GET IT
Times cited: 8
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2013 Academic Article GET IT
Times cited: 29
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2013 Academic Article GET IT
Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. American heart journal. 2013 Academic Article GET IT
Times cited: 25
Recurrent coronary artery thrombosis after anomalous right coronary artery re-implantation to the aorta. 2013 GET IT
Times cited: 2
The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention. The Journal of invasive cardiology. 2013 Academic Article GET IT
Times cited: 8
Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 7
Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 21
Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. The Journal of invasive cardiology. 2013 Academic Article GET IT
Times cited: 7
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2013 Academic Article GET IT
Times cited: 32
Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes. JACC. Cardiovascular interventions. 2012 Academic Article GET IT
Times cited: 41
Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. American heart journal. 2012 Academic Article GET IT
Times cited: 5
Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial. Journal of the American College of Cardiology. 2012 Academic Article GET IT
Times cited: 113
Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study. American heart journal. 2012 Academic Article GET IT
Times cited: 5
Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature. Current cardiology reports. 2012 Review GET IT
Times cited: 11
Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction. Circulation. Cardiovascular interventions. 2012 Academic Article GET IT
Times cited: 10
Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. Journal of the American College of Cardiology. 2012 Academic Article GET IT
Times cited: 52
Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Journal of the American College of Cardiology. 2012 Academic Article GET IT
Times cited: 37
Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2012 Academic Article GET IT
Times cited: 55
Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial. International journal of cardiology. 2012 Academic Article GET IT
Times cited: 8
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012 Academic Article GET IT
Times cited: 419
Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes. JACC. Cardiovascular imaging. 2012 Academic Article GET IT
Times cited: 22
Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI). The American journal of cardiology. 2012 Academic Article GET IT
Times cited: 45
Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. European heart journal. 2012 Academic Article GET IT
Times cited: 180
Risks and complications of coronary angiography: a comprehensive review. Global journal of health science. 2012 Review GET IT
Times cited: 201
Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: the harmonizing outcomes with revascularization and stents in AMI (HORIZONS-AMI) trial. American heart journal. 2011 Academic Article GET IT
Times cited: 23
The accuracy of the electrocardiogram during exercise stress test based on heart size. PloS one. 2011 Academic Article GET IT
Times cited: 1
Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention. American heart journal. 2011 Academic Article GET IT
Times cited: 13
Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials). The American journal of cardiology. 2011 Academic Article GET IT
Times cited: 40
Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing. American heart journal. 2011 Academic Article GET IT
Times cited: 6
Flow-dependent changes resulting in restoration of patency of the left internal mammary artery graft after documented atresia. 2011 GET IT
Times cited: 3
Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention. The American journal of cardiology. 2011 Academic Article GET IT
Times cited: 7
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 2011 Review GET IT
Times cited: 217
Relationship between the angiographically derived SYNTAX score and outcomes in high-risk patients undergoing percutaneous coronary intervention. The Journal of invasive cardiology. 2011 Academic Article GET IT
Times cited: 9
The relationship between late lumen loss and restenosis among various drug-eluting stents: a systematic review and meta-regression analysis of randomized clinical trials. Atherosclerosis. 2010 Review GET IT
Times cited: 22
Is implantation of drug-eluting stents a Faustian choice?. The Journal of invasive cardiology. 2010 Comment GET IT
Why we do what we do? Making sense of antithrombotic therapy in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. JACC. Cardiovascular interventions. 2010 Editorial Article GET IT
The aorta wall of patients presenting to the emergency department with acute myocardial infarction by cardiac magnetic resonance. Atherosclerosis. 2010 Academic Article GET IT
Times cited: 3
Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. American heart journal. 2010 Academic Article GET IT
Times cited: 9
Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction. The American journal of medicine. 2010 Review GET IT
Times cited: 16
Precision and accuracy of risk scores for in-hospital death after percutaneous coronary intervention in the current era. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2010 Academic Article GET IT
Times cited: 12
Measuring the right compound at the right time is not always easy. The Journal of invasive cardiology. 2010 Comment GET IT
Antithrombin therapy for elective percutaneous coronary intervention: which agent to use? Does it matter?. JACC. Cardiovascular interventions. 2009 Editorial Article GET IT
Three-year survival after percutaneous coronary intervention according to appropriateness criteria for revascularization. The Journal of invasive cardiology. 2009 Academic Article GET IT
Times cited: 8
Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. American heart journal. 2009 Academic Article GET IT
Times cited: 7
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?. Journal of the American College of Cardiology. 2009 Editorial Article GET IT
Times cited: 9
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. European heart journal. 2009 Academic Article GET IT
Times cited: 139
The pain and the gain of treating patients with acute coronary syndromes-can the two be separated?. American heart journal. 2009 Editorial Article GET IT
Times cited: 2
Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. Journal of the American College of Cardiology. 2008 Academic Article GET IT
Times cited: 46
Influence of coronary artery stenosis severity and coronary collateralization on extent of chronic myocardial scar: insights from quantitative coronary angiography and delayed-enhancement MRI. The open cardiovascular medicine journal. 2008 Academic Article GET IT
Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library. Contemporary clinical trials. 2008 Academic Article GET IT
Times cited: 10
Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. JACC. Cardiovascular interventions. 2008 Academic Article GET IT
Times cited: 15
The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression. The Journal of invasive cardiology. 2008 Academic Article GET IT
Times cited: 2
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation. 2008 Academic Article GET IT
Times cited: 173
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. European heart journal. 2008 Academic Article GET IT
Times cited: 50
Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. American heart journal. 2008 Academic Article GET IT
Times cited: 8
Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. American heart journal. 2008 Academic Article GET IT
Times cited: 98
Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. The American journal of cardiology. 2007 Academic Article GET IT
Times cited: 94
Universal definition of myocardial infarction. Circulation. 2007 Conference Paper GET IT
Times cited: 2153
Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. The Journal of invasive cardiology. 2007 Academic Article GET IT
Times cited: 15
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?. Journal of the American College of Cardiology. 2007 Academic Article GET IT
Times cited: 90
Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials. American heart journal. 2006 Academic Article GET IT
Times cited: 40
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. Journal of the American College of Cardiology. 2006 Review GET IT
Times cited: 134
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. The American journal of cardiology. 2006 Academic Article GET IT
Times cited: 21
Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. The American journal of cardiology. 2006 Academic Article GET IT
Times cited: 26
Insights into the pathophysiology of ST-elevation myocardial infarction. American heart journal. 2006 Review GET IT
Times cited: 23
CABG or PCI? An interventional cardiologist's perspective. To stent or to operate: is this the question?. Cleveland Clinic journal of medicine. 2006 Editorial Article GET IT
Wish list and REALITY: choice of stents and end points for treatment of de novo coronary artery lesions. JAMA. 2006 Editorial Article GET IT
Times cited: 2
Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction. Archivos de cardiologia de Mexico. 2006 Academic Article GET IT
Times cited: 2
Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. European heart journal. 2005 Academic Article GET IT
Times cited: 77
Primary percutaneous coronary intervention for acute MI: improving access and outcomes. Cleveland Clinic journal of medicine. 2005 Review GET IT
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial. American heart journal. 2005 Academic Article GET IT
Times cited: 9
Relation of myocardial perfusion to mortality after primary percutaneous coronary intervention. The American journal of cardiology. 2005 Academic Article GET IT
Times cited: 10
GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention. American heart journal. 2004 Academic Article GET IT
Times cited: 7
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2004 Academic Article GET IT
Times cited: 35
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation. 2004 Review GET IT
Times cited: 145
Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004 Academic Article GET IT
Times cited: 238
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. American heart journal. 2004 Review GET IT
Times cited: 89
Adjunctive therapy for percutaneous revascularization in acute myocardial infarction. Current pharmaceutical design. 2004 Review GET IT
Times cited: 9
New fibrinolytic agents for MI: as effective as current agents, but easier to administer. Cleveland Clinic journal of medicine. 2004 Review GET IT
Times cited: 13
Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation. The American journal of cardiology. 2003 Academic Article GET IT
Times cited: 16
Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003 Academic Article GET IT
Times cited: 1179
Images in cardiovascular medicine. Tako-tsubo--like transient left ventricular dysfunction. 2003 GET IT
Times cited: 34
Abciximab-facilitated percutaneous coronary intervention and long-term survival--a prospective single-center registry. European heart journal. 2003 Academic Article GET IT
Times cited: 16
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. The American journal of cardiology. 2003 Academic Article GET IT
Times cited: 7
A randomized multicenter trial comparing a new, low-pressure versus a conventional coronary stent: primary results from the CONSERVE trial. The Journal of invasive cardiology. 2003 Academic Article GET IT
Times cited: 1
Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on one-year event-free survival. The American journal of cardiology. 2003 Academic Article GET IT
Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. Journal of the American College of Cardiology. 2002 Academic Article GET IT
Times cited: 155
Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes. The American journal of cardiology. 2002 Academic Article GET IT
Times cited: 43
Early invasive strategies for acute coronary syndromes. Current cardiology reports. 2002 Review GET IT
Frequency and long-term impact of myonecrosis after coronary stenting. European heart journal. 2002 Academic Article GET IT
Times cited: 137
Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. American heart journal. 2002 Academic Article GET IT
Times cited: 8
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. The American journal of cardiology. 2002 Academic Article GET IT
Times cited: 30
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial. Journal of the American College of Cardiology. 2002 Academic Article GET IT
Times cited: 117
Epicardial versus microcirculatory dissociation. European heart journal. 2002 Editorial Article GET IT
Times cited: 2
beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation. 2001 Academic Article GET IT
Times cited: 35
Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. The American journal of cardiology. 2001 Academic Article GET IT
Times cited: 86
Platelet glycoprotein IIb/IIIa receptor inhibition in primary angioplasty for acute myocardial infarction: The new paradigm of direct revascularization. International journal of cardiovascular interventions. 2001 Academic Article GET IT
Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials. Circulation. 2001 Review GET IT
Times cited: 212
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions. Circulation. 2000 Academic Article GET IT
Times cited: 59
Troponin, embolization and restoration of microvascular integrity. European heart journal. 2000 Editorial Article GET IT
Times cited: 16
The benefit of abciximab in percutaneous coronary revascularization is not device-specific. The American journal of cardiology. 2000 Academic Article GET IT
Times cited: 22
Does coronary angiography before emergency aortic surgery affect in-hospital mortality?. Journal of the American College of Cardiology. 2000 Academic Article GET IT
Times cited: 50
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. American heart journal. 2000 Academic Article GET IT
Times cited: 33
Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations. Cleveland Clinic journal of medicine. 2000 Review GET IT
Times cited: 2
Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])]. The American journal of cardiology. 1999 Academic Article GET IT
Times cited: 3
Factors leading to progression of valvular aortic stenosis. The American journal of cardiology. 1999 Academic Article GET IT
Times cited: 106
Logic and logistics: conundrum in reperfusion treatment for acute myocardial infarction. Heart (British Cardiac Society). 1999 Editorial Article GET IT
Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial. The American journal of cardiology. 1999 Academic Article GET IT
Times cited: 25
Rapport?. Circulation. 1999 Letter GET IT
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. Journal of the American College of Cardiology. 1998 Academic Article GET IT
Times cited: 130
Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation. 1998 Academic Article GET IT
Times cited: 730
Angioplasty or fibrinolysis for acute MI? The GUSTO IIb study. Cleveland Clinic journal of medicine. 1998 Review GET IT
Times cited: 2
A profile of candidates for repeat myocardial revascularization: implications for selection of treatment. The Journal of thoracic and cardiovascular surgery. 1997 Academic Article GET IT
Times cited: 16
Late myocardial ischemic events after saphenous vein graft intervention--importance of initially "nonsignificant" vein graft lesions. The American journal of cardiology. 1997 Academic Article GET IT
Times cited: 91
Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. The American journal of cardiology. 1997 Academic Article GET IT
Times cited: 48
A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I Trial). Coronary Angioplasty Versus Excisional Atherectomy Trial-I. The American journal of cardiology. 1996 Academic Article GET IT
Times cited: 34
Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery. The American journal of cardiology. 1996 Academic Article GET IT
Times cited: 126
Chronotropic response to exercise predicts angiographic severity in patients with suspected or stable coronary artery disease. The American journal of cardiology. 1995 Academic Article GET IT
Times cited: 43
Value of tongue biting in the diagnosis of seizures. Archives of internal medicine. 1995 Academic Article GET IT
Times cited: 116
Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. Journal of the American College of Cardiology. 1995 Academic Article GET IT
Times cited: 138
Permanent pacing following repeat cardiac valve surgery. The American journal of cardiology. 1994 Academic Article GET IT
Times cited: 35

more ...

less ...

Background

education and training

M.D., Hadassah Medical School, The Hebrew University (Israel) 1984
B.S., Hebrew University (Israel) 1980

Contact

full name

Sorin Jakob Brener

primary email

sjb9005@nyp.org

VIVO Weill Cornell Medical College

Sorin Jakob Brener Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email